Table 4 The comparison with metachronous GA and without metachronous GA

Sex

M

71

6 (8%)

0.4

1.47

0.40–5.48

F

68

4 (6%)

Age

60≦

64

1 (2%)

0.02^※

8.59

1.06–69.78

60>

75

9 (12%)

Histology of Lymphoma

DLBCL

83

10 (12%)

0.007^※

-

-

MALT

51

0

HP Infection

HP positive

22

5 (23%)

0.007^※

-

-

HP negative

34

0

Chemotherapy

Yes

88

10 (11%)

0.009^※

-

-

No

51

0

Rituximab

Yes

40

3 (8%)

0.59

1.07

0.26–4.34

No

99

7 (7%)

Stage

Stage I

93

3 (3%)

0.02^※

5.38

1.32–21.92

Stage II-IV

46

7 (15%)

Chronic Gastritis

Yes

65

9 (14%)

0.26

3.05

0.36–25.71

No

20

1 (5%)

Intestinal Metaplasia

Yes

29

6 (21%)

0.07

3.39

0.87–13.17

No

56

4 (7%)